Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 838 | 1,225 | 1,115 | 1,454 | 2,183 |
| Gross Profit | 838 | 1,225 | 1,115 | 1,454 | 2,183 |
| Operating Expenses | 49,446 | 55,198 | 54,492 | 53,846 | 46,405 |
| Operating Income | -48,608 | -53,973 | -53,377 | -52,392 | -44,222 |
| Other Income | 2,529 | 3,391 | 786 | 502 | 1,946 |
| Pre-tax Income | -46,079 | -50,582 | -52,591 | -51,890 | -42,276 |
| Net Income Continuous | -46,079 | -50,582 | -52,591 | -51,890 | -42,276 |
| Net Income | $-46,079 | $-50,582 | $-52,591 | $-51,890 | $-42,276 |
| EPS Basic Total Ops | -0.22 | -0.32 | -0.41 | -0.40 | -0.31 |
| EPS Basic Continuous Ops | -0.23 | -0.32 | -0.41 | -0.40 | -0.31 |
| EPS Diluted Total Ops | -0.22 | -0.32 | -0.41 | -0.40 | -0.31 |
| EPS Diluted Continuous Ops | -0.23 | -0.32 | -0.41 | -0.40 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.32 | -0.41 | -0.40 | -0.31 |
| EBITDA(a) | $-47,520 | $-52,666 | $-51,924 | $-50,856 | $-42,650 |